Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
This trial is active, not recruiting.
|Condition||osteoarthritis of the hip|
|Sponsor||Rothman Institute Orthopaedics|
|Trial identifier||NCT00951145, RIFJPAR 09-01|
This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.
The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem
Proximally coated tapered stems can be used for patients with various bone types, bone morphology, and underlying diagnosis
Male or female participants of any age.
Inclusion Criteria: 1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem. 2. Patients with hip fracture undergoing THA will also be included. 3. Patients willing and able to comply with follow-up requirements and self-evaluations.
|Official title||Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem|
|Principal investigator||Parvizi Javad, MD|
Call for more information